옵젠 (OPGN)

OpGen (NASDAQ:OPGN) Shares to Reverse Split on Monday, May 20th - Defense World

Defense World

OPGN’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

The InvestChronicle

OpGen (NASDAQ:OPGN) Receives New Coverage from Analysts at StockNews.com - Defense World

Defense World

OpGen Announced 1-for-10 Reverse Stock Split - GlobeNewswire

GlobeNewswire

OpGen Announced 1-for-10 Reverse Stock Split

GlobeNewswire Inc.

OpGen, Inc. (OPGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

GoodRx Holdings, Inc. (GDRX) Misses Q1 Earnings Estimates

Zacks Investment Research

StockNews.com Begins Coverage on OpGen (NASDAQ:OPGN) - Defense World

Defense World

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

OpGen Provides Update on Business Operations - citybiz

citybiz

OpGen Provides Update on Business Operations and Strategic Opportunities

GlobeNewswire Inc.

OpGen Provides Update on Business Operations and Strategic Opportunities - OpGen, Inc.

OpGen, Inc.

OpGen Gets Notice of Noncompliance From Nasdaq - Marketscreener.com

Marketscreener.com

OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

GlobeNewswire Inc.

OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K - Yahoo Finance

Yahoo Finance

OpGen Inc Announces David Lazar as New CEO - TipRanks.com - TipRanks

TipRanks

OpGen Inc Announces David Lazar as New CEO - TipRanks.com - TipRanks

TipRanks

Opgen Inc (OPGN) Shares See Highest Trading Level at $0.71 – DWinneX - The Dwinnex

The Dwinnex

OpGen Inc Secures $3M Investment, Enhances Corporate Structure - TipRanks.com - TipRanks

TipRanks

DC daily roundup: Meta's anti-trans hate problem; Key Bridge collapse's supply chain impact; OpGen has a new CEO - Technical.ly

Technical.ly

OpGen CEO Oliver Schacht resigns, David Lazar to succeed following investment - TipRanks.com - TipRanks

TipRanks

Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates

Benzinga

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Dow Gains 100 Points; McCormick Posts Upbeat Results

Benzinga

Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February

Benzinga

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket

Benzinga

Rockville biotech OpGen attracts investment, appoints new CEO amid struggles - Washington Business Journal - The Business Journals

The Business Journals

OpGen Announces Acquisition of Preferred Stock by David Lazar

GlobeNewswire Inc.

Opgen Announces Acquisition Of Preferred Stock By David Lazar - XM

XM

OpGen Inc Granted Extension to Meet Nasdaq Compliance - TipRanks.com - TipRanks

TipRanks

OpGen Inc. Extends Warrant Exercise Deadline to 2024 - TipRanks.com - TipRanks

TipRanks

OpGen Inc Reports Unregistered Equity Sales Update - TipRanks.com - TipRanks

TipRanks

Shutdowns, layoffs, stock delistings: Biotech's bad year - Washington Business Journal - The Business Journals

The Business Journals

DMV Empanadas closing, reopening in Gaithersburg - MoCo360

MoCo360

Rockville biotech OpGen shrinks headcount, scales down U.S. operations - Washington Business Journal - The Business Journals

The Business Journals

OpGen (NASDAQ: OPGN) stock - as we said, wild speculation now down 74% from peak - Dhaka Tribune

Dhaka Tribune

OpGen (NASDAQ: OPGN) up 611% - this is a wild, perhaps crazed, speculation - Dhaka Tribune

Dhaka Tribune

Why Is OpGen (OPGN) Stock Up 115% Today? - InvestorPlace

InvestorPlace

OpGen's Subsidiary Curetis and FIND Extend R&D Collaboration Agreement - OpGen, Inc.

OpGen, Inc.

OpGen Announces Exercise of All Prefunded Warrants - OpGen, Inc.

OpGen, Inc.

OpGen Announces $3.38 Million Registered Direct Offering - OpGen, Inc.

OpGen, Inc.

OpGen Announces Pricing of $7.5 Million Public Offering - GlobeNewswire

GlobeNewswire

OpGen Announced 1-for-20 Reverse Stock Split - citybiz

citybiz

OpGen Announces Successful Completion of Unyvero A30 Development Milestone - OpGen, Inc.

OpGen, Inc.

The panel combatting the rise of antibiotic resistance in UTIs - European Pharmaceutical Manufacturer

European Pharmaceutical Manufacturer

OpGen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022 and Provides ... - GlobeNewswire

GlobeNewswire

OpGen Announces Results of Special Meeting of Stockholders - GlobeNewswire

GlobeNewswire

Antibiotics Development & Drug Resistance Insights - European Pharmaceutical Manufacturer

European Pharmaceutical Manufacturer

OpGen Announces $15 Million Registered Direct Offering - OpGen, Inc.

OpGen, Inc.

Unyvero Safety Data Sheets - OpGen, Inc.

OpGen, Inc.